NCT00148213
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +4 more
- Locations
-
- Department of Nuclear Medicine, Münster University Hospital Münster, Germany
Clinical trial condition
Head and Neck Neoplasms
Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.
3,750 public trials
1,059 recruiting studies
Head and Neck Neoplasms trial results
NCT00041808
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
- Locations
-
- Scripps Stevens Cancer Division San Diego, California, United States
- UCSF Cancer Center San Francisco, California, United States
- Scott and White Clinic Temple, Texas, United States
- Frankfurt Universtiy Frankfurt, Germany
NCT00002043
- Conditions
- AIDS-Related Complex, AIDS-Related Opportunistic Infections, Bacterial Infections and Mycoses, +38 more
- Locations
-
- UCLA CARE Ctr Los Angeles, California, United States
NCT00002026
- Conditions
- AIDS-Related Complex, AIDS-Related Opportunistic Infections, Blood-Borne Infections, +31 more
- Locations
-
- Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States
Active, Not Recruiting
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
NCT01142388
- Conditions
- Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +21 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- The Medical Center of Aurora Aurora, Colorado, United States
- Boulder Community Foothills Hospital Boulder, Colorado, United States
Active, Not Recruiting
Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer
NCT02567422
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Carcinoma of Unknown Primary, +17 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
- Yale University New Haven, Connecticut, United States
Active, Not Recruiting
Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers
NCT05669664
- Conditions
- Head and Neck Neoplasms, Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, +9 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
Active, Not Recruiting
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT00588770
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +48 more
- Locations
-
- Providence Hospital Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
Active, Not Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
NCT02465060
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
Active, Not Recruiting
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
NCT03811015
- Conditions
- Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Head and Neck Neoplasms, +8 more
- Locations
-
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States